MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,826,000 | -46.5% | 114,726 | -0.2% | 0.12% | -33.9% |
| Q1 2016 | $5,283,000 | -21.9% | 114,902 | -17.9% | 0.18% | -16.3% |
| Q4 2015 | $6,768,000 | -80.1% | 140,000 | -82.5% | 0.22% | -71.4% |
| Q3 2015 | $34,000,000 | -25.6% | 800,000 | +100.0% | 0.75% | -17.1% |
| Q2 2015 | $45,680,000 | -11.5% | 400,000 | 0.0% | 0.91% | -13.8% |
| Q1 2015 | $51,628,000 | +29.6% | 400,000 | 0.0% | 1.05% | +27.0% |
| Q4 2014 | $39,845,000 | +0.7% | 400,000 | 0.0% | 0.83% | -8.0% |
| Q3 2014 | $39,549,000 | +28.3% | 400,000 | 0.0% | 0.90% | +30.4% |
| Q2 2014 | $30,832,000 | +19.7% | 400,000 | 0.0% | 0.69% | +23.8% |
| Q1 2014 | $25,749,000 | +0.9% | 400,000 | 0.0% | 0.56% | -1.2% |
| Q4 2013 | $25,528,000 | +6.5% | 400,000 | 0.0% | 0.56% | -2.4% |
| Q3 2013 | $23,976,000 | +21.8% | 400,000 | 0.0% | 0.58% | +13.3% |
| Q2 2013 | $19,680,000 | – | 400,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |